Abstract
Bacteria often adopt a sessile biofilm lifestyle that is resistant to antimicrobial treatment1,2,3,4,5. Opportunistic pathogenic bacteria like Pseudomonas aeruginosa can develop persistent infections1,2,3. To gain insights into the differences between free-living P. aeruginosa cells and those in biofilms, and into the mechanisms underlying the resistance of biofilms to antibiotics, we used DNA microarrays. Here we show that, despite the striking differences in lifestyles, only about 1% of genes showed differential expression in the two growth modes; about 0.5% of genes were activated and about 0.5% were repressed in biofilms. Some of the regulated genes are known to affect antibiotic sensitivity of free-living P. aeruginosa. Exposure of biofilms to high levels of the antibiotic tobramycin caused differential expression of 20 genes. We propose that this response is critical for the development of biofilm resistance to tobramycin. Our results show that gene expression in biofilm cells is similar to that in free-living cells but there are a small number of significant differences. Our identification of biofilm-regulated genes points to mechanisms of biofilm resistance to antibiotics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745 (1995).
Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).
Burns, J. L., Ramsey, B. W. & Smith, A. L. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis. Adv. Pediatr. Infect. Dis. 8, 53–66 (1993).
DeBeer, D., Stoodley, P. & Lewandowski, Z. Liquid flow in heterogenous biofilms. Biotech. Bioeng. 44, 636–641 (1994).
Lawrence, J. R., Korber, D. R., Hoyle, B. D., Costerton, J. W. & Caldwell, D. E. Optical sectioning of microbial biofilms. J. Bacteriol. 173, 6558–6567 (1991).
Hoiby, N. Antibiotic therapy for chronic infection of pseudomonas in the lung. Annu. Rev. Med. 44, 1–10 (1993).
Singh, P. K. et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764 (2000).
O'Toole, G. A. & Kolter, R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304 (1998).
Bangera, M. G., Ichikawa, J. K., Marx, C. & Lory, S. in Am. Soc. Microbiol. 100th Gen. Meeting (ASM Press, Los Angeles, 2000).
Costerton, J. W. et al. Biofilms, the customized microniche. J. Bacteriol. 176, 2137–2142 (1994).
Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959–964 (2000).
Hill, D. F., Short, N. J., Perham, R. N. & Petersen, G. B. DNA sequence of the filamentous bacteriophage Pf1. J. Mol. Biol. 218, 349–364 (1991).
Zabriskie, J. B. Viral-induced bacterial toxins. Annu. Rev. Med. 17, 337–350 (1966).
Johnson, J. A., Morris, J. G. & Kaper, J. B. Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J. Clin. Microbiol. 31, 732–733 (1993).
Greenberg, E. P. Bacterial genomics: Pump up the versatility. Nature 406, 947–948 (2000).
Hancock, R. E. W. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38, 237–264 (1984).
Nikaido, H. & Vaara, M. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49, 872–878 (1985).
Bryan, L. E. & Kwan, S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23, 835–845 (1983).
Bryan, L. E., Nicas, T., Holloway, B. W. & Crowther, C. Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase. Antimicrob. Agents Chemother. 17, 71–79 (1980).
Damper, P. D. & Epstein, W. Role of membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20, 803–808 (1981).
Bryan, L. E., Haraphongse, R. & Elzen, H. M. V. D. Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J. Antibiot. (Tokyo) 29, 743–753 (1976).
MacLeod, D. L. et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J. Infect. Dis. 181, 1180–1184 (2000).
Rivera, M., Hancock, R. E., Sawyer, J. G., Haug, A. & McGroarty, E. J. Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 32, 649–655 (1988).
Suh, S. J. et al. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J. Bacteriol. 181, 3890–3897 (1999).
Heydorn, A. et al. Experimental reproducibility in flow-chamber biofilms. Microbiology 146, 2409–2415 (2000).
Whiteley, M., Parsek, M. R. & Greenberg, E. P. Regulation of quorum sensing by RpoS in Pseudomonas aeruginosa. J. Bacteriol. 182, 4356–4360 (2000).
Hoiby, N. Pseudomonas in Cystic Fibrosis: Past, Present and Future 1–25 (Cystic Fibrosis Trust, Berlin, 1998).
Davies, D. G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295–298 (1998).
Hentzer, M. et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183, 5395–5401 (2001).
Ichikawa, J. K. et al. Interaction of Pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc. Natl Acad. Sci. USA 97, 9659–9664 (2000).
Acknowledgements
We thank T. Moninger for assistance with electron microscopy and A. Hay for providing information on E. coli biofilm gene expression in advance of publication. Supported by a grant from the National Institutes of Health (E.P.G.), a New Technologies Grant from the Cystic Fibrosis Foundation (S.L.), and a grant from the Procter & Gamble Company (E.P.G.). M.W. was supported by a National Science Foundation Research Training Grant and a US Public Health Service Training Grant. G.M.T. is supported by a National Science Foundation Center Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whiteley, M., Bangera, M., Bumgarner, R. et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413, 860–864 (2001). https://doi.org/10.1038/35101627
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35101627
This article is cited by
-
Lytic activity of phages against bacterial pathogens infecting diabetic foot ulcers
Scientific Reports (2024)
-
Biofilm and wound healing: from bench to bedside
European Journal of Medical Research (2023)
-
Antibiofilm activity from endophyte bacteria, Vibrio cholerae strains, and actinomycetes isolates in liquid and solid culture
BMC Microbiology (2023)
-
Diadenosine tetraphosphate modulated quorum sensing in bacteria treated with kanamycin
BMC Microbiology (2023)
-
Genomic variability correlates with biofilm phenotypes in multidrug resistant clinical isolates of Pseudomonas aeruginosa
Scientific Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.